Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1979 Dec 1;2(6202):1396–1398. doi: 10.1136/bmj.2.6202.1396

Praziquantel: a new schistosomicide against Schistosoma haematobium.

J E McMahon, N Kolstrup
PMCID: PMC1597073  PMID: 519476

Abstract

The effectiveness of the new schistosomicide praziquantel was assessed in African schoolchildren infected with Schistosoma haematobium. They were stratified according to the severity of their infection and were then randomly allocated to treatment with two single-dose regimens (30 and 40 mg/kg) and a split regimen of two doses of 20 mg/kg given four hours apart. All three regimens were highly effective and produced few side effects. Children who initially had very high pretreatment egg loads showed a poorer therapeutic response at all dose levels, and further investigations are necessary to find the optimum dose. Because of its effectiveness in a single dose and lack of toxicity, praziquantel may prove to be the ideal schistosomicide.

Full text

PDF
1399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRADLEY D. J. A quantitative approach to bilharzia. East Afr Med J. 1963 May;40:240–249. [PubMed] [Google Scholar]
  2. Davis A. Comparative trials of antimonial drugs in urinary schistosomiasis. Bull World Health Organ. 1968;38(2):197–227. [PMC free article] [PubMed] [Google Scholar]
  3. Davis A. Field trials of ambilhar in the treatment of urinary bilharziasis in schoolchildren. Bull World Health Organ. 1966;35(6):827–835. [PMC free article] [PubMed] [Google Scholar]
  4. Gönnert R., Andrews P. Praziquantel, a new board-spectrum antischistosomal agent. Z Parasitenkd. 1977 Jul 21;52(2):129–150. doi: 10.1007/BF00389899. [DOI] [PubMed] [Google Scholar]
  5. James C., Webbe G., Nelson G. S. The susceptibility to praziquantel of Schistosoma haematobium in the baboon (Papio anubis) and of S. japonicum in the vervet monkey (Cercopithecus aethiops). Z Parasitenkd. 1977 Jul 21;52(2):179–194. doi: 10.1007/BF00389902. [DOI] [PubMed] [Google Scholar]
  6. McMahon J. E., Kilala C. P. Clinical trial with Ambilhar in Schistosoma mansoni infections in Tanzania. Br Med J. 1966 Oct 29;2(5521):1047–1049. doi: 10.1136/bmj.2.5521.1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Webbe G., James C. A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters. Z Parasitenkd. 1977 Jul 21;52(2):169–177. doi: 10.1007/BF00389901. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES